Brief: Diamyd Gets Notice Of Allowance For Key Patent
11/06/2026 08:02
BRIEF-Diamyd Gets Notice Of Allowance For Key Patent June 11 (Reuters) - Diamyd Medical AB DMYDb.ST:
RECEIVES USPTO NOTICE OF ALLOWANCE FOR RETOGATEIN PATENT IN TYPE 1 DIABETES
PATENT VALID UNTIL 2038, STRENGTHENS DIAMYD MEDICAL'S GLOBAL IP PORTFOLIO
Source text: ID:nWkr4BG9G3
Further company coverage: [DMYDb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))